<DOC>
	<DOCNO>NCT00194883</DOCNO>
	<brief_summary>Children chronic kidney failure often grow well . This study examine possible cause growth failure child response recombinant human growth hormone . The growth hormone-insulin-like growth factor axis study relation biochemical immunological parameter well body compositional change pre- post recombinant human growth hormone therapy .</brief_summary>
	<brief_title>Effect Cytokines Growth Children With Chronic Kidney Failure</brief_title>
	<detailed_description>Children chronic renal failure ( CRF ; estimate creatinine clearance le 75ml/min/1.73 m2 ) end-stage renal disease ( ESRD ; dialysis dependent ) mark growth retardation often achieve expect height base genetic potential despite adequate caloric supplementation , recently , rhGH treatment . Resistance endogenous rhGH propose account much growth failure , although specific mechanism remain unknown . Possibilities include insensitivity GH inappropriate production IGF-I and/or reduce bioavailability secondary alter GH-IGF axis . Abnormalities GH/IGF-I axis may result inability growth plate chondrocyte respond appropriately . Studies combine data nutritional parameter , change body composition bone density , bone turnover GH-IGF axis-related protein child CRF ESRD lack . We propose characterize specific mechanism underlie impaired growth pre-pubertal pubertal child CRF ESRD growth failure prior initiation rhGH therapy . The Specific Aims proposal design allow efficacious use rhGH maximize growth child . In study measurement total body composition , i.e. , lean body mass , fat mass bone mineral content make use dual photon X-ray absorptiometry . Bone mineral density also determine . These study correlate anthropometric , biochemical nutritional assessment patient rhGH treatment . Letin cytokines concomitantly measure . Bone collagen turnover quantitated use pyridinoline deoxypyridinoline cross-link excretion ( CRF patient ) serum level collagen type I C-terminal propeptide ( CICP ) concomitant measurement . Bone turnover assess look additional biochemical marker bone metabolism osteocalcin bone alkaline phosphatase . Serum level IGF-I , IGF-II , intact fragment IGFBP-1 , -2 , -3 , GH GH-binding activity determine rhGH therapy correlate measurement make study . These study help elucidate difference rhGH responsiveness population . Taken together , study substantially advance understand rhGH improve growth child CRF ESRD .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Current height &lt; 2SD ( &lt; 3rd percentile ) chronological age Chronic renal failure ( estimate creatinine clearance &lt; 75 mL/min/1.73m2 ) ESRD ( define receive maintenance HD PD ) Age &lt; 21 year /or growth potential demonstrable bone age Unable unwilling adhere protocol Additional diagnosis could impair responsiveness GH , e.g . dwarfism syndrome , significant extrarenal organ disease , e.g . chronic liver disease , chronic corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Recombinant Human Growth Hormone</keyword>
	<keyword>Leptin</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Chronic Renal Insufficiency</keyword>
	<keyword>Children</keyword>
</DOC>